Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2010 - 2026)

Pacific Biosciences Of California's Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $48.2 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 57.47% year-over-year to $48.2 million; the TTM figure through Mar 2026 stood at -$65.2 million (down 388.3% YoY), while the FY2024 annual figure was $34.9 million, down 95.47% from the prior year.
• Change in Acquisitions & Divestments was $48.2 million for Q1 2026 at Pacific Biosciences Of California, up from -$280.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $355.4 million in Q3 2022 to a low of -$355.4 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $50.2 million across 5 years, with a median of $84.6 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments jumped 27068.07% in 2024, then slumped 1145.3% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$355.4 million in 2022, then soared by 138.9% to $138.3 million in 2023, then slumped by 80.62% to $26.8 million in 2024, then plunged by 1145.3% to -$280.1 million in 2025, then surged by 117.23% to $48.2 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $48.2 million (Q1 2026), -$280.1 million (Q4 2025), and $84.6 million (Q3 2025), per Business Quant data.